Internal Medicine, Hematology & Oncology · Brooklyn, NY
NPI
1013214535
Since 2011
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
757 60th St Fl 5
Brooklyn, NY, 11220
Phone (718) 439-3250
Groups this clinician bills Medicare through
Medicare paid, 2024
$70K
1,754 services
Medicare patients, 2024
86
Average age 79
Drug cost, 2024
$14.4M
3,884 prescriptions
Company payments, 2025
$26K
From 35 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Songchuan Guo was code 85025 (blood count), 263 times for 48 patients. In total Songchuan Guo billed 1,754 services in 32 codes, and Medicare paid $70K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-09-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 85025 Blood Count | Office | 263 | 48 | $7.61 | $2,001 |
| 99213 Office E&M - Established | Office | 260 | 70 | $75.07 | $20K |
| 36415 Venipuncture Blood Collection | Office | 143 | 35 | $8.65 | $1,237 |
| 96367 Intravenous Infusion, Hydration | Office | 136 | 13 | $25.80 | $3,509 |
| J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 128 | 16 | $1.04 | $133 |
| 96413 Chemotherapy Administration | Office | 123 | 16 | $115.00 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 119 | 54 | $14.05 | $1,672 |
| 99214 Office E&M - Established | Office | 111 | 31 | $110.90 | $12K |
| 96372 Injection Administration | Office | 98 | 12 | $12.10 | $1,186 |
| 99497 Care Management/Coordination | Office | 29 | 28 | $71.45 | $2,072 |
| 99204 Office E&M - New | Office | 17 | 17 | $139.80 | $2,377 |
By year: 2022 $339K for 22,994 services; 2023 $111K for 6,791 services; 2024 $70K for 1,754 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 263 | 48 | $7.61 | $2,001 |
| 36415 Venipuncture Blood Collection | 143 | 35 | $8.65 | $1,237 |
Medicare prescription drug claims, 2024
In 2024, the drug Songchuan Guo prescribed most often to Medicare patients was Dexamethasone Sodium Phosphate, with 375 prescriptions and refills. In total Songchuan Guo wrote 3,884 Medicare prescriptions that cost $14.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dexamethasone Sodium Phosphate Generic | 375 | 375 | 93 | $1,383 |
| Tagrisso Osimertinib Mesylate | 202 | 202 | 37 | $3.3M |
| Keytruda Pembrolizumab | 178 | 178 | 28 | $1.9M |
| Palonosetron Hcl Generic | 168 | 168 | 55 | $25K |
| Anastrozole Generic | 166 | 264 | 29 | $1,665 |
| Aprepitant Generic | 151 | 151 | 47 | $42K |
| Ondansetron Odt Ondansetron | 128 | 128 | 81 | $1,490 |
| Ondansetron Hcl Ondansetron Hcl/Pf | 105 | 105 | 27 | $274 |
| Carboplatin Generic | 89 | 89 | 35 | $4,858 |
| Omeprazole Generic | 73 | 75 | 19 | $685 |
| Hydroxyurea Generic | 72 | 101 | 16 | $1,090 |
| Opdivo Nivolumab | 70 | 70 | 15 | $735K |
| Pemetrexed Disodium Generic | 66 | 66 | 13 | $121K |
| Oxaliplatin Generic | 66 | 66 | 22 | $151K |
| Triamcinolone Acetonide Generic | 61 | 62 | 28 | $1,125 |
Brand drugs: - claims; generic drugs: 2,548 claims; opioid claims: 68.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Songchuan Guo $26K ($26K in general payments such as food, travel and fees) from 35 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $19K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 15 | $19K |
| Daiichi Sankyo Inc. 4568.T | 12 | $3,576 |
| Janssen Biotech, Inc. JNJ | 17 | $411 |
| Pfizer Inc. PFE | 26 | $408 |
| Merck Sharp & Dohme LLC MRK | 10 | $234 |
| Astellas Pharma US Inc 4503.T | 9 | $217 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $192 |
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $183 |
| Exelixis Inc. EXEL | 8 | $160 |
| BeOne Medicines USA, Inc. ONC | 6 | $158 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.